Most importantly, this formulation noticeably diminished the protein expressions of P-gp and MRP1 (Fig. 11c), which further confirmed the excellent repressive effect of this formulation on MDR transporter-mediated resistance in CRC cells. Here, PGP is linked to colorectal carcinoma.